Literature DB >> 2732100

Trypan blue in vivo stains nigral dopaminergic neurons killed by 6-hydroxydopamine.

G J Lees1.   

Abstract

Dopaminergic neurons in the substantia nigra killed by 6-hydroxydopamine were stained in vivo by intracerebral injections of trypan blue. Such staining appeared specific for dead neurons, although a proportion of these retained the ability to stain with Nissl dyes for at least 2 days. Neurons retained trypan blue in vivo for periods of up to 9 days. Trypan blue staining of some neurons outside the substantia nigra demonstrated the use of this dye in determining the degree of non-specific toxicity of 6-hydroxydopamine. Twenty-four hours after infusion of trypan blue almost no background staining was present and individually stained neurons were clearly visible. Thus the use of trypan blue may have a general application as a sensitive method for estimating discrete areas of toxin-induced neuronal death, and for estimating the degree of specificity of a toxin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2732100     DOI: 10.1007/bf00493013

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  9 in total

1.  Partial selectivity of 6-OHDA induced neuronal degeneration after intraissular injection in the brain with special reference to the nigro-striatal dopamine system.

Authors:  F Javoy
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

Review 2.  Pharmacological actions of 6-hydroxydopamine.

Authors:  R M Kostrzewa; D M Jacobowitz
Journal:  Pharmacol Rev       Date:  1974-09       Impact factor: 25.468

3.  Specificity of 6-hydroxydopamine induced degeneration of central monoamine neurones: an electron and fluorescence microscopic study with special reference to intracerebral injection on the nigro-striatal dopamine system.

Authors:  T Hökfelt; U Ungerstedt
Journal:  Brain Res       Date:  1973-10-12       Impact factor: 3.252

4.  Relationship between sensorimotor neglect and the specificity, degree and locus of mesotelencephalic dopaminergic cell loss following 6-hydroxydopamine.

Authors:  G J Lees; R R Kydd; J J Wright
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

5.  Evidence that punctate intracerebral administration of 6-hydroxydopamine fails to produce selective neuronal degeneration. Comparison with copper sulfate and factors governing the deportment of fluids injected into brain.

Authors:  L L Butcher; S M Eastgate; G K Hodge
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

6.  Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine system.

Authors:  F Javoy; C Sotelo; A Herbet; Y Agid
Journal:  Brain Res       Date:  1976-02-06       Impact factor: 3.252

7.  Intracranial injections of 6-OHDA. Comparison of catecholamine-depleting effects of different volumes and concentrations.

Authors:  G L Willis; G Singer; B K Evans
Journal:  Pharmacol Biochem Behav       Date:  1976-08       Impact factor: 3.533

8.  Non-specific histopathological changes induced by the intracerebral injection of 6-hydroxy-dopamine (6-OH-DA).

Authors:  L J Poirier; P Langelier; A Roberge; R Boucher; A Kitsikis
Journal:  J Neurol Sci       Date:  1972-08       Impact factor: 3.181

9.  The ascending projections of the dopaminergic neurons of the substantia nigra, zona reticulata: a combined retrograde tracer-immunohistochemical study.

Authors:  A Y Deutch; M Goldstein; R H Roth
Journal:  Neurosci Lett       Date:  1986-11-21       Impact factor: 3.046

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.